Long‐term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients

To investigate the long‐term outcome and prognostic factors of juvenile dermatomyositis (DM) through a multinational, multicenter study.

[1]  B. Feldman,et al.  Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. , 2008, Arthritis and rheumatism.

[2]  B. Feldman,et al.  Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood , 2008, The Lancet.

[3]  N. Wulffraat,et al.  Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study. , 2007, Arthritis and rheumatism.

[4]  L. Wedderburn,et al.  The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr. , 2006, Rheumatology.

[5]  B. Feldman,et al.  Advances in the treatment of juvenile dermatomyositis , 2006, Current opinion in rheumatology.

[6]  A. Dyer,et al.  Duration of illness is an important variable for untreated children with juvenile dermatomyositis. , 2006, The Journal of pediatrics.

[7]  B. Feldman,et al.  Long-term outcomes in juvenile dermatomyositis: How did we get here and where are we going? , 2005, Current rheumatology reports.

[8]  A. Reiff,et al.  Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage. , 2004, Arthritis and rheumatism.

[9]  P. Lachenbruch,et al.  Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. , 2004, Arthritis and rheumatism.

[10]  G. Serratrice,et al.  International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. , 2004, Rheumatology.

[11]  W. Kuis,et al.  Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. , 2003, Rheumatology.

[12]  C. Oddis.  Idiopathic inflammatory myopathies: A treatment update , 2003, Current rheumatology reports.

[13]  A. Dyer,et al.  US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. , 2003, Arthritis and rheumatism.

[14]  R. Bode,et al.  Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. , 2003, Arthritis and rheumatism.

[15]  R. Sundel,et al.  Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. , 2002, Journal of the American Academy of Dermatology.

[16]  S. Cavuto,et al.  Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. , 2001, Clinical and experimental rheumatology.

[17]  B. Feldman,et al.  Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. , 2000, Arthritis and rheumatism.

[18]  L. Pachman,et al.  Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. , 1999, Arthritis and rheumatism.

[19]  A. Prieur,et al.  Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids. , 1998, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[20]  D. Symmons,et al.  The incidence of juvenile dermatomyositis: results from a nation-wide study. , 1995, British journal of rheumatology.

[21]  J. Fries,et al.  Measurement of health status in children with juvenile rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[22]  B. Bernstein,et al.  Course of treated juvenile dermatomyositis. , 1984, The Journal of pediatrics.

[23]  C. Blane,et al.  Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. , 1983, The Journal of pediatrics.

[24]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[25]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .